Tech Company Inital Public Offerings
Akoya Biosciences IPO
On 4/20/2021, Akoya Biosciences went public.
Transaction Overview
Company Name
Announced On
4/20/2021
Transaction Type
IPO
Amount
$131,600,000
Proceeds Purpose
We expect to use the net proceeds from this offering for general corporate purposes, which may include, but are not limited to, expanding our commercial operations, funding our research and development efforts to advance our platform of technologies, capital expenditures and funding working capital. We may also use a portion of the net proceeds for acquisitions of, or strategic investments in, complementary businesses, products, services, or technologies.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Campus Dr. 6th Floor
Marlborough, MA 01752
USA
Marlborough, MA 01752
USA
Phone
Website
Email Address
Overview
Akoya Biosciences' history represents the rapid advancement driving the field of multiplexed biomarker analysis and immunofluorescence tissue analysis. Today's Akoya portfolio spans the spectrum from powerful tools for discovery of important biomarkers to clinical research applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian McKelligon
Chief Financial Officer
Joseph Driscoll
President
Terry Lo
Vice President
Cliff Hoyt
VP - Marketing
Chris Streck
VP - Operations
Seth Benson
VP - R & D
Julia Kennedy-Darling
VP - R & D
Peter Miller
VP - Sales
Paul Grass
Browse more venture capital transactions:
Prev: 4/20/2021: Adagio Therapeutics venture capital transaction
Next: 4/21/2021: Candex venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs